Drugs / Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed
Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05237947 Comparator | Mar 2022 → Aug 2026 overdue | cervical carcinoma | National Cancer Institute (NCI) | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05237947 ↗ |
| Modality | Vaccine | “diphtheria toxoid/tetanus toxoid/acellular pertussis vaccine adsorbed vaccine (Adacel)” NCT05237947 ↗ |
| Route | Intramuscular | “Given IM” NCT05237947 ↗ |